Skip to main content

Table 1 Association between A148T variants and selected types of cancer

From: Low-risk Genes and Multi-organ Cancer Risk in the Polish Population

  A148T OR 95% Confidence Interval p (adjusted p)  
total controls (n = 3000) 105 (3.5%) G/A      
bladder (n = 223) 0 (0%) A/A 7 (3.1%) G/A 0.9 0.4105-1.945 0.7764 (n.s)
colon (n = 724) 0 (0%) A/A 37 (5.1%) G/A 1.5 1.012-2.180 0.0423 (0.5499)
stomach (n = 246) 0 (0%) A/A 8 (3.3%) G/A 0.9 0.4461-1.925 0.8384 (n.s)
larynx (n = 396) 0 (0%) A/A 17 (4.3%) G/A 1.2 0.7326-2.088 0.4255 (n.s)
ovary (n = 340) 0 (0%) A/A 12 (3.5%) G/A 1.0 0.5491-1.853 0.9777 (n.s)
lung (n = 497) 0 (0%) A/A 34 (6.8%) G/A 2.0 1.358-3.018 0.0004 (0.0052)
prostate (n = 348) 0 (0%) A/A 13 (3.7%) G/A 1.1 0.5946-1.925 0.8215 (n.s)
kidney (n = 264) 0 (0%) A/A 6 (2.3%) G/A 0.6 0.2788-1.474 0.2915 (n.s)
thyroid (n = 173) 0 (0%) A/A 3 (1.7%) G/A 0.5 0.1528-1.549 0.2129 (n.s)
non-Hodgkin Lymphoma (n = 162) 0 (0%) A/A 6 (3.7%) G/A 1.1 0.4585-2.453 0.8909 (n.s)
breast (under 50 y) (n = 3318) 0 (0%) A/A 168 (5.1%) G/A 1.5 1.2764-1.832 0.002  
melanoma (n = 471) 0 (0%) A/A 33 (7%) G/A 2.1 1.387-3.111 0.0003  
pancreas (n = 210) 0 (0%) A/A 8 (3.8%) G/A 1.1 0.5246-2.273 0.8140 (n.s)